C17H19N5O2
Neat
325.37
3016399-21-3; Ruxolitinib Impurity E; GZ27HR4YZX; SCHEMBL20548737; 1H-Pyrazole-1-propanoic acid, beta-cyclopentyl-4-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-; 3-(4-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanoic acid; 3-Cyclopentyl-3-[4-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)pyrazol-1-yl]propanoic acid; beta-Cyclopentyl-4-(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanoic acid and (+/-)-
3-cyclopentyl-3-[4-(7H-pyrrolo[2 and 3-d]pyrimidin-4-yl)pyrazol-1-yl]propanoic acid
InChI=1S/C17H19N5O2/c23-15(24)7-14(11-3-1-2-4-11)22-9-12(8-21-22)16-13-5-6-18-17(13)20-10-19-16/h5-6,8-11,14H,1-4,7H2,(H,23,24)(H,18,19,20)